D.E. Shaw & Co
ALAB icon

D.E. Shaw & Co’s Astera Labs ALAB Stock Holding History

D.E. Shaw & Co’s Portfolio ALAB Stock Details ALAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.93M Sell
81,500
-35,200
-30% -$5.01M 0.01% 1736
2025
Q4 		$19.4M Sell
116,700
-7,600
-6% -$1.27M 0.01% 1260
2025
Q3 		$24.3M Sell
124,300
-86,400
-41% -$14.2M 0.01% 1048
2025
Q2 		$19.1M Sell
210,700
-117,700
-36% -$9.3M 0.01% 1064
2025
Q1 		$19.6M Buy
328,400
+136,100
+71% +$12.6M 0.02% 961
2024
Q4 		$25.5M Buy
+192,300
New +$18M 0.02% 894

Other funds holding ALAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

D.E. Shaw & Co's ALAB Position: Q1 2026 in Review

D.E. Shaw & Co reduced its Astera Labs (ALAB) stake by 38% in Q1 2026, selling an estimated $133M and leaving 1,519,561 shares worth $167M. The position accounts for 0.1% of the portfolio, ranked #232.

D.E. Shaw & Co first reported a position in ALAB in Q4 2024 and has held it in 6 quarters since. The position peaked at $499M in Q3 2025. 703 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • D.E. Shaw & Co held 1,519,561 shares of Astera Labs worth $167M as of Q1 2026.
  • D.E. Shaw & Co sold 932,819 Astera Labs shares in Q1 2026, an estimated $133M.
  • Astera Labs made up 0.1% of D.E. Shaw & Co's portfolio in Q1 2026, its #232 holding.
  • D.E. Shaw & Co first reported a position in Astera Labs in Q4 2024 and has held it in 6 quarters since.
  • D.E. Shaw & Co's Astera Labs position peaked at $499M in Q3 2025.
  • 703 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.